MoneyWorks4Me

A fair growth of 16.65% in the revenue at Rs. 16500.10 millions was reported in the March 2025 quarter as compared to Rs. 14145.20 millions during year-ago period.The company almost doubled its revenue to Rs. 2519.00 millions  from Rs. 1213.20 millions in the quarter ended March 2025.OP of the company witnessed a marginal growth to 4669.90 millions from 2952.00 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 16500.10 14145.20 16.65 52169.80 48123.90 8.41 52169.80 48123.90 8.41
Other Income 721.60 240.90 199.54 1004.70 474.20 111.87 1004.70 474.20 111.87
PBIDT 4669.90 2952.00 58.19 10448.00 7973.00 31.04 10448.00 7973.00 31.04
Interest 486.00 419.90 15.74 1822.00 1508.20 20.81 1822.00 1508.20 20.81
PBDT 4183.90 2532.10 65.23 8626.00 6464.80 33.43 8626.00 6464.80 33.43
Depreciation 881.90 889.00 -0.80 3587.90 3450.10 3.99 3587.90 3450.10 3.99
PBT 3302.00 1643.10 100.96 5038.10 3014.70 67.12 5038.10 3014.70 67.12
TAX 783.00 429.90 82.14 1234.20 777.70 58.70 1234.20 777.70 58.70
Deferred Tax -37.70 -29.50 27.80 -304.20 -101.70 199.12 -304.20 -101.70 199.12
PAT 2519.00 1213.20 107.63 3803.90 2237.00 70.04 3803.90 2237.00 70.04
Equity 1078.50 1077.90 0.06 1078.50 1077.90 0.06 1078.50 1077.90 0.06
PBIDTM(%) 28.30 20.87 35.62 20.03 16.57 20.88 20.03 16.57 20.88
Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..